SCN2A

Wishing the SCN2A community a healthy, happy and bright 2020. In 2020, we will take further steps to improve the lives of those whose lives are affected by SCN2A. With clinical trials and potential new treatments on the horizon we are hopeful for a brighter future. #SCN2A

Want to hear the latest news on SCN2A? Sign up to our newsletter here scn2aaustralia.org Updates on the Natural History Study, potential trials in 2020 (and beyond), the resources available for families & the medical profession and MORE. #SCN2A #SCN2AInsights #cureSCN2A

PODCAST: When Alex Nemiroff’s son Roger was born, he was determined to work towards finding treatments for #SCN2A. Alex is now the CEO of RogCon, which has a research program (RC-222) developing a ASO for GOF epilepsies. scn2aaustrlia.org/podcast-3/ omny.fm/shows/scn2a/pa… #SCN2A

Exciting times in the SCN2A world. Looking forward to this webinar 👇

Look out soon for some news on companies with advanced #SCN2A programs, including one planning to start human trials next year!

GETA PRESENTATION 2019 - Prof. Steve Petrou. The Importance of Disease Mechanism in Therapy: Lessons from SCN1A #SCN1A #Dravet #GETA2019 #geneticepilepsy geneticepilepsyteam.com.au/conference-201…

Here’s looking at you, #GETA2019! Thanks for joining us in Melbourne from around Australia and across the Pacific ⁦@GlobalGenes⁩ ⁦@Kcnq2Cure⁩ #genetics #Epilepsy

Interested in genetic epilepsy? Don’t miss our genetic epilepsy conference on May 4th 09:00 Melbourne time (UTC+10). Speakers include @ingridscheffer, @drkbhowell, Steven Petrou, Daniel Lowenstein, Emma Palmer and Annapurna Poduri. geneticepilepsyteam.com.au/conference-201… #geneticepilepsy

The International SCN2A Natural History Study (NSH) is underway. Registry versus NHS? events-support.com/Documents/Pari… #naturalhistorystudy #NHS #SCN2A #cureSCN2A

Meaningful story by @Spectrum of the positive impact a genetic test can have on a person with autism. ms.spr.ly/6011T8hKJ Our desire for patients to see these benefits drives our mission of offering affordable options for gene panels, #WES & #WGS

The #FamilieSCN2A Foundation is excited to announce the 2019 "Action Potential" grant will be accepting applications starting February 1, 2019. Letters of Intent are by due March 1, 2019. Learn more @ mailchi.mp/scn2a.org/acti… #ActionPotential #CureSCN2A #SCN2A

This is such an important concept that has been demonstrated several times now. Treating #ADHD in children with #epilepsy does not increase risk of #seizures. If the child needs treatment of this common comorbity of epilepsy, it is ok to treat!

International Natural History Study on SCN2A Mutations! prnewswire.com/news-releases/…

Announcing the launch SCN2A Australia. We look forward to working with families, researchers, clinicians and professional bodies to improve the lives of those who have SCN2A and their families. Follow us to keep up with the latest on SCN2A. #SCN2A #geneticepilepsy #autism

For our very 1st #WarriorWednesday of 2019 we'd like to kick it off by honoring SCN2A Warriors Leah Schust and Carla Forbes (our Founder/President & Co-Founder/Vice President). There are not enough words of praise for these two SCN2A mamas! #SCN2A #CureSCN2A

RogCon Biosciences Launches with Late-Breaking Presentation on SCN2A Epilepsy at the 2018 AES Mee... finance.yahoo.com/news/rogcon-bi… via @YahooFinance

Interesting paper underscoring the ability to impact SCN2A patients at later stages.

Visual depiction of why #SCN2A differs from all the other monogenetic causes of #autism. twitter.com/Channelopath_2…